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Background: Tocotrienols, especially the gamma isomer was discovered to possess cytotoxic effects associated
with the induction of apoptosis in numerous cancers. Individual tocotrienol isomers are believed to induce
dissimilar apoptotic mechanisms in different cancer types. This study was aimed to compare the cytotoxic potency
of alpha-, gamma- and delta-tocotrienols, and to explore their resultant apoptotic mechanisms in human lung
adenocarcinoma A549 and glioblastoma U87MG cells which are scarcely researched.
Methods: The cytotoxic effects of alpha-, gamma- and delta-tocotrienols in both A549 and U87MG cancer cells
were first determined at the cell viability and morphological aspects. DNA damage types were then identified by
comet assay and flow cytometric study was carried out to support the incidence of apoptosis. The involvements of
caspase-8, Bid, Bax and mitochondrial membrane permeability (MMP) in the execution of apoptosis were further
expounded.
Results: All tocotrienols inhibited the growth of A549 and U87MG cancer cells in a concentration- and time-dependent
manner. These treated cancer cells demonstrated some hallmarks of apoptotic morphologies, apoptosis was further
confirmed by cell accumulation at the pre-G1 stage. All tocotrienols induced only double strand DNA breaks (DSBs) and
no single strand DNA breaks (SSBs) in both treated cancer cells. Activation of caspase-8 leading to increased levels of Bid
and Bax as well as cytochrome c release attributed by the disruption of mitochondrial membrane permeability in both
A549 and U87MG cells were evident.
Conclusions: This study has shown that delta-tocotrienol, in all experimental approaches, possessed a higher efficacy
(shorter induction period) and effectiveness (higher induction rate) in the execution of apoptosis in both A549 and
U87MG cancer cells as compared to alpha- and gamma-tocotrienols. Tocotrienols in particular the delta isomer can be an
alternative chemotherapeutic agent for treating lung and brain cancers.
Keywords: Tocotrienol isomers, Cytotoxicity, Apoptosis, DNA damage, Caspase-8, Bid, Bax, Mitochondrial membrane
permeability, Cytochrome cBackground
Cancer is one of the leading causes of death globally. Ac-
cording to American Cancer Society [1], one in eight
deaths is caused by cancer. An estimation of about 7
million people dies from cancer each year and is pre-
dicted to rise to 21.4 million new cases and 13.2 million
deaths by 2030 [2].* Correspondence: Sandy.Loh@nottingham.edu.my
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unless otherwise stated.Many previous studies have proposed that vitamin E can
be a candidate for adjuvant treatment of tumorigenesis
and it plays an imperative role in the prevention and oc-
currence of cancer [3]. Tocotrienols and tocopherols are
naturally occurring isoforms of vitamin E that are found
abundantly in food such as palm oil, rice bran oil, corn,
oats, barley, rye and wheat [4-7]. Both isoforms have sub-
stantial antioxidant activity that may enhance their useful
biological effects [6,7]. Tocotrienols generally possess
more remarkable anticancer potential than tocopherols
[6,8,9]. And, desmethyl tocotrienols (delta- and gamma-is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 IC50, IC80 and ICmax concentrations of all
tocotrienols used in different experiments
Cell lines A549 U87MG
Concentrations (μM) IC50 IC80 ICmax IC50 IC80 ICmax
Alpha-tocotrienol 5.0 60.0 100.0 2.0 10.0 100.0
Gamma-tocotrienol 2.0 10.0 100.0 3.0 60.0 100.0
Delta-tocotrienol 2.0 10.0 100.0 1.0 10.0 100.0
Values are obtained from the concentration-response curves plotted using
probit or logistic analysis in Graphpad Prism (version 5) bio-statistical software.
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the other isomers making desmethyl tocotrienols more
favorable as potential anticancer candidates [10].
Numerous studies predominantly focusing on gamma-
tocotrienol have been reported to possess antiprolifera-
tive effects against breast cancer [6,11-13], liver cancer
[14], colon cancer [7], gastric adenocarcinoma [15],
prostate cancer [16-18] and lung cancer [19]. However,
further studies are still required to completely explain
the mechanisms for tocotrienol-induced apoptosis, at-
tributable in part to its antiproliferative effects on can-
cer cells. As referred to the above-mentioned reports,
tocotrienols might induce different mechanisms of ac-
tion in different cancer cell types.
These interesting previous studies have captured our
attention in investigating the cytotoxic effects and
underlying apoptotic mechanisms of alpha-, gamma-
and delta-tocotrienols on human lung adenocarcinoma
(A549) and glioblastoma (U87MG) cells which are still
scarcely studied.
Methods
Tocotrienol isomers, cell lines and culture conditions
The palm oil derived alpha-, gamma- and delta-tocotrienol
isomers were extracted and supplied in palm vitamin E
isomers kit by Davos Life Science Pte Ltd (Singapore).
The human lung adenocarcinoma (A549), grade IV glio-
blastoma (U87MG) and normal lung fibroblast (MRC5)
were grown and maintained at the similar conditions as
previously published papers [20,21].
Cell viability assessment assay
Neutral red uptake assay was performed to determine
the cell viability based on an established protocol [22]. A
total of 5 x 103 cells per well were seeded in a 96-well
plate (Nunc, USA) and incubated for 24 h. All cell lines
were then treated with alpha-, gamma- and delta-
tocotrienols at the concentrations ranging from 1 μM to
100 μM for 24 h, 48 h and 72 h. Vinblastine was used as
a positive control at the concentrations ranging from
0.011 μM to 11 μM. The percentage of cell viability was
calculated using the formula: (ODtreated/ODuntreated ×
100%) taking into the account of vehicle control un-
treated cells.
Morphological characterization by staining techniques
Morphological assessments for cellular changes, viability
and apoptosis in response to each tocotrienol isomer
treatment were conducted via haematoxylin and eosin
(H&E), acridine orange and propidium iodide (AO&PI)
as well as fluorescein diacetate and propidium iodide
(FDA&PI) staining techniques. Guided by the neutral red
uptake assay, cells grown in chamber slides (Lab-Tek,
USA) were treated with the IC50 and IC80 values (Table 1)of each tocotrienol isomer for 24 h and 48 h. The H&E
procedure was adopted as previously published papers
[20,21]. On the other hand, 10 μl of fluorescent dyes con-
taining AO (10 μg/ml) and PI (10 μg/ml) were added onto
the prepared cells. For FDA&PI staining, 2.5 μg/ml of
FDA (Sigma, USA) and 1.5 μg/ml of PI (Invitrogen, USA)
were prepared freshly as dyes. Treated and vehicle control
cells were washed three times in PBS, stained in 200 μl of
PBS containing dyes and examined immediately using
Eclipse 80i research microscope with an epifluorescence il-
luminator attachment (Nikon, Japan). At least 200 cells in
each sample were observed for features showing viability,
early and late apoptosis in addition to secondary necrosis.
Percentage of cells categorized at distinguished stages of
apoptosis was also recorded.
Determination of DNA damage by comet assay
Single cell gel electrophoresis (SCGE or comet) assay
(Trevigen, USA) was used to determine the effects of
alpha-, gamma- and delta-tocotrienols (72 h treatment)
on nuclear DNA damage according to previously re-
ported protocols [20,21]. Comets that appeared under
neutral conditions provided evidence of double strand
breaks (DSBs); whereas comets produced under alkaline
conditions indicated single strand breaks (SSBs). The
tocotrienol isomers were tested at IC50 concentrations in
both cancer cells (Table 1) and vinblastine (0.011 μM
and 11 μM) was served as a positive control. Previous
reports [20,21,23] were followed for visual image analysis
and scoring of DNA damage.
Cell cycle phase evaluation by flow cytometry
A total of 1 × 106 cells per well were seeded in a 6-well
plate (Orange Scientific, Belgium) and incubated for
24 h. Cells were then treated with the IC50 and IC80
values (Table 1) of tocotrienol isomers for 24 h and
48 h. Following a standard harvest procedure, cells were
resuspended in 400 μl of fluorochrome solution (0.1%
Triton-X-100; 0.1% sodium citrate; 0.1 mg/ml RNase;
50 μg/ml PI) and stored in dark at 4°C overnight. Then,
the samples were homogenously mixed before subjected
for cell cycle analysis in a flow cytometry machine in-
stalled with EXPO32 software (Beckman Coulter Ltd,
UK). Triplicates of each sample were analyzed.
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A total of 1 × 105 cells/ml were seeded and grown in
60 mm2 petri dishes. Cell lines were tested at different
concentrations of tocotrienol isomers (Table 1) and vin-
blastine at 0.011 μM and 11 μM concentrations. Guided
by a kinetic study (see Additional file 1), the 1 h treat-
ment period was found to be optimal for all concentra-
tions tested for the detection of caspase-8 initiation. To
authenticate the caspase-8 involvement, cells were pre-
incubated with 10 μM and 30 μM of caspase-8 inhibitor,
z-IETD-fmk (Z-Ile-Glu-Thr-Asp-fmk) for 30 min and
then exposed to each tocotrienol isomer. Caspase-8 col-
orimetric assay (GenScript, USA) was employed to
quantify the caspase-8 activity in treated cell lines ac-
cording to manufacturer’s instructions. Treated cells (in
the absence or presence of caspase-8 inhibitor) were first
collected into microcentrifuge tubes and centrifuged at
2,200 rpm for 5 min. Following two washes of pelleted
cells with PBS, ice-cold lysis buffer (50 μl) containing
0.5 μl dithiothreitol (DTT) and 0.25 μl phenylmethane-
sulfonylfluoride (PMSF) was added into the collected
cells and mixed well. The cells were then incubated on
ice for 45 min with intermittent vortexing for 4 times,
each for 10 sec. The cells were then subjected to centri-
fugation at 10,000 rpm for 1 min. Supernatants (50 μl)
were transferred into wells of a 96-well plate; 50 μl of 2
x reaction buffer (containing 0.5 μl DTT and 0.25 μl
PMSF) and 5 μl of caspase-8 substrate (IETD-pNA) were
added to each sample. Samples were then incubated at
37°C for 1 h in the dark. The cleavage of labeled sub-
strate IETD-pNA into chromophore p-nitroanilide
(pNA) was determined by measuring the absorbance
(optical density, OD) at 405 nm using a 96-well micro-
plate reader (Thermo Fisher Scientific, USA). The result
of the induced caspase-8 activity was obtained by com-
puting ODinducer/ODnegative controls with the background
OD values from cell lysates and buffers subtracted.
Determination of Bid and cytochrome c activities by ELISA
The detection of human Bcl-2 homology domain 3 or
BH-3 interacting domain death agonist (Bid) and cyto-
chrome c was conducted by using enzyme-linked im-
munosorbent assay (ELISA). A total of 1 × 106 cells/ml
were seeded and grown in 60 mm2 petri dish. The cells
were then treated with IC50 and ICmax concentrations of
tocotrienol isomers (Table 1) for 4 h, alongside with an
untreated negative control included. In order to study
the correlation of caspase-8 with Bid and cytochrome c
in the whole apoptotic execution, the cells were pre-
incubated with 50 μM of caspase-8 inhibitor, z-IETD-
fmk for 30 min prior tocotrienol treatment. The treated
cells were diluted with 1 × PBS to reach cell density at
1 × 108/ml and then stored overnight at −20°C. Cell ly-
sates were centrifuged at 5,000 × g for 5 min at 4°C. Thesupernatant was collected and tested for standard ELISA
procedures on Bid and cytochrome c levels according to
manufacturer’s protocol (CUSABIO, USA).
Western blotting assay for Bax detection
A total of 1 × 106 cells/ml were seeded and grown in
100 mm2 petri dish. The cells were then treated with the
IC50 concentration of each tocotrienol isomer (Table 1)
for 24 h. Total protein (100 μg per well) was loaded onto
a 10% SDS-PAGE followed by standard electrophoresis
and electro-blotting transfer procedures. The blotted
membrane was blocked with 10% milk for 24 h at 4°C.
Membrane was rinsed thrice with Tris Buffer Saline
Tween (TBST) (8 g/L Na Cl; 2.42 g/L Tris and 0.05%
Tween 20; pH 7.6), each for 10 min. The membrane was
incubated with the primary rabbit monoclonal antibody
against Bax (Cell Signaling Technology, USA) (1: 1,000 di-
luted in TBST containing 5% milk) for 24 h at 4°C. Mean-
while, detection of beta-actin was used as a protein
loading control. Following 3-time TBST washes (each for
10 min), the membrane was then incubated with second-
ary anti-rabbit antibody (1: 4,000 diluted in TBST) (Cell
Signaling Technology, USA) for 1 h at room temperature
with gentle shaking. After similar washing steps, LumiPico
ECL kit (ShineGene, China) was used to detect the immo-
bilized protein on the membrane using chemiluminescent
method according to the manufacturer’s instructions.
Mitochondrial membrane permeability assessment assay
Mitochondrial membrane permeability (MMP) was mea-
sured using a mitochondrial apoptosis detection kit as
described by the manufacturer (Genscript, USA). Briefly,
about 1 × 106 cells were seeded on chamber slides
(Lab-Tek, USA) for 24 h. In the presence or absence of
caspase-8 inhibitor z-IETD-fmk, cells were treated
with IC50 and ICmax concentrations of alpha-, gamma-
and delta-tocotrienols (Table 1) for 3 h and 24 h; and
vinblastine was tested at 0.011 μM and 11 μM concen-
trations for comparison. Following a washing step with
PBS, the cells were immersed in 1 ml of diluted JC-1
reagent and incubated for 20 min. More than 200 cells
in each replicate were analyzed instantly under an
epifluorescence microscope (Nikon, Japan) using a band-
pass filter. Cells that appeared in red fluorescence in-
dicated MitoCapture JC-1 reagent accumulation in the
intact mitochondria of healthy cells whereas cells that with
changed MMP would fluoresce in green.
Statistical analysis
The concentration-response curves were plotted by
using probit or logistic analysis and the IC50, IC80 and
ICmax values were then calculated by using Graphpad
Prism (version 5) bio-statistical software. In general,
quantitative experimental data were expressed as
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cates performed in three separate occasions for each
group. When necessary, a standard curve was created by
using the same software for target quantitation purpose.
Unpaired or independent t test and ANOVA (using
completely randomized design, CRD) were used to com-
pare between two groups or to compare between groups.
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Figure 1 Effects of different concentrations and treatment periods of to
(B) gamma- and (C) delta-tocotrienols show significant cytotoxic effects (p < 0
manner. Cell viability is presented as percentage where negative vehicle cont
(n = 9). α-T3: alpha-tocotrienol; γ-T3: gamma-tocotrienol; δ-T3: delta-tocotrienoResults
Cytotoxic effects of cancer cells treated with tocotrienols
The effects of various concentrations of alpha-, gamma-
and delta-tocotrienols on the proliferation of both A549
and U87MG cell lines after defined treatment periods
are shown in Figure 1. Treatments with alpha-, gamma-
and delta-tocotrienols at the range between 1 μM and
100 μM significantly inhibited (p < 0.05) the cell viability3
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cotrienols on cell viability of A549 and U87MG cells. (A) Alpha-,
.05) against both cancer cells in a concentration- and time-dependent
rol cells were regarded as 100% viable. Data are presented as mean ± SD
l.
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values for alpha-, gamma- and delta-tocotrienols at 24, 48
and 72 h are shown in Table 2. Increased concentrations
in the treatment had resulted in reduced cell numbers and
enhanced cell death. On the other hand, all tocotrienol
isomers were found not causing apparent impairment to-
wards the non-cancerous MRC5 cells where IC50 >
100 μM. Overall results showed that delta-tocotrienol ex-
hibited the most potent cytotoxicity towards both A549
and U87MG cells, followed by gamma-tocotrienol and
then alpha-tocotrienol. Delta-tocotrienol seemed to pos-
sess comparable antiproliferative activity towards both
A549 and U87MG cells, whereas, gamma-tocotrienol pos-
sessed 1.5 times lower IC50 value in A549 than that of
U87MG cells. As opposed to that, alpha-tocotrienols was
found to possess 3 times lower IC50 value in U87MG
when compared to A549 cells. In comparison to tocotrie-
nols, vinblastine possessed higher cytotoxic potency with
lower IC50 values for both cancer cell lines, i.e. < 0.055 μM
(0.01 μg/ml for A549 and 0.05 μg/ml for U87MG cells, re-
spectively as published previously [21]).
Morphological alterations of cancer cells treated with
tocotrienols
Following histochemical and fluorescence staining, mor-
phological characteristics of cellular apoptotic death
such as nuclear fragmentation, chromatin condensation,
multinucleated cells, vesicles formation, cytoplasmic ex-
tension, cell blebbing and formation of apoptotic bodies
were evident microscopically in all alpha-, gamma- and
delta-tocotrienols treated A549 and U87MG cancer cells
at their respective IC50 and IC80 concentrations. Treated
MRC5 cells exhibited a mild degree of cellular stress
morphologies such as tiny vesicles formation and cyto-
plasmic extension. A few representative images are
shown in Figure 2. Vehicle control untreated cancer
cells were observed with a green intact nuclear structure
(Figure 2A). Early apoptosis was detected by the evidence
of obvious intercalated AO within the fragmented DNA.
Nuclear chromatin condensation was observed during
mid-apoptosis (Figure 2B-D). Meanwhile, the later stagesTable 2 Mean IC50 values of A549 and U87MG cells
receiving treatments of tocotrienols
Mean IC50 Concentration (μM)
Cell lines A549 U87MG
Treatment
period
24 h 48 h 72 h 24 h 48 h 72 h
Alpha-
tocotrienol
5.46 ± 0.8 4.93 ± 0.4 4.61 ± 1.7 2.57 ± 0.1 1.84 ± 0.2 1.53 ± 0.4
Gamma-
tocotrienol
2.84 ± 0.1 2.56 ± 0.2 1.72 ± 0.2 5.02 ± 0.1 3.75 ± 0.1 3.32 ± 0.3
Delta-
tocotrienol
1.71 ± 0.4 1.60 ± 0.1 1.27 ± 0.2 1.45 ± 0.1 1.29 ± 0.1 1.13 ± 0.9
Each value is expressed as a mean ± SD (n = 9).of apoptosis can be evident by changes such as the pres-
ence of reddish-orange colour in cells, owing to the bin-
ding of AO to denatured DNA and penetration of PI stain
through the nuclear membranes that losing their perme-
ability (Figure 2B-D).
Differential scoring of treated cells stained with AO&PI
for the quantification of viable, early apoptotic, late apop-
totic and secondary necrotic morphologies showed that all
alpha-, gamma- and delta-tocotrienols were found to
trigger morphological features related to apoptosis in a
concentration- and time-dependent manner. As referred
to Table 3, alpha-tocotrienol was found to cause the high-
est percentage of early apoptosis in A549 cells, whereas in
the case of U87MG cells, the highest percentage of cells
was at the mid stage of apoptosis. Gamma-tocotrienol
caused the highest percentage of mid stage apoptotic cells,
whereas, delta-tocotrienol produced the highest late stage
apoptotic cells in both A549 and U87MG cells.
Overall results indicated that all alpha-, gamma- and
delta-tocotrienols showed impressively significant (p <
0.05) apoptotic effects in both A549 and U87MG cells as
compared to the vehicle control untreated cells. There
was no statistically significant (p > 0.05) difference in nec-
rotic counts at different treatment times. Some MRC5
cells were found undergoing apoptosis when treated with
50 μM of alpha-, gamma- and delta-tocotrienols, however,
the number of apoptotic cells was < 20% and statistically
insignificant (p > 0.05).
Under FDA&PI fluorescent staining (Figure 2E-H), the
numbers of survived cells with changed morphology
and dead cells which stained in red were highly dependent
on the concentrations of alpha-, gamma- and delta-
tocotrienols tested. Maximal quantities of cell death
found in A549 and U87MG cells, respectively, receiving
the treatment of IC80 concentrations were 77% and 95% for
alpha-tocotrienol, 97% and 84% for gamma-tocotrienol,
and 100% in both cells for delta-tocotrienol. The frequency
of dead cells in the vehicle control untreated A549 and
U87MG cells did not exceed 1% at the end of the experi-
ment and necrotic cells were not observed.
DNA damage pattern of cancer cells treated with
tocotrienols
The induction of apoptotic cell death by alpha-, gamma-
and delta-tocotrienols was examined for the involvement
of DNA damage in A549 and U87MG cells by comet
assay. Alpha-, gamma- and delta-tocotrienols treated
A549 and U87MG cells showed well-formed comets
while the vehicle control untreated cancer and normal
cells did not demonstrate any comet-like appearance
(Figure 3) indicating no DNA damage or breakage. All
tocotrienol isomers were found to produce only double
strand breaks (DSBs, neutral comets) but no single




























Figure 2 Representative AO&PI and FDA&PI staining images of A549 and U87MG cells treated with tocotrienols. Following a treatment
period of 24 h, (A,E) untreated vehicle control cells show normal appearance with no prominent apoptotic and necrotic cells. In AO&PI staining,
A549 and U87MG cells treated with IC50 of (B) alpha-, (C) gamma- and (D) delta-tocotrienols show early apoptosis exhibiting a bright-green
nucleus as condensation of chromatin (white arrows), and late apoptosis demonstrating cellular blebbing and nuclear margination (white and red
arrowhead). FDA&PI stained A549 and U87MG cells treated with IC50 of (F) alpha-, (G) gamma- and (H) delta-tocotrienols show cell death with
higher red fluorescence evidenced as compared to the untreated cells (E). Bar (AO&PI): 10 μm; Bar (FDA&PI): 50 μm; α-T3: alpha-tocotrienol; γ-T3:
gamma-tocotrienol; δ-T3: delta-tocotrienol.
Table 3 Percentage of tocotrienols-treated A549 and U87MG cells categorized at different stages of apoptosis
Treatment at IC50 Cells categorized at different phases of apoptosis (%)
A549 U87MG
Early Mid Late Early Mid Late
Alpha-tocotrienol 57.6 28.5 15.1 22.3 70.7 8.8
Gamma-tocotrienol 11.4 63.1 26.3 35.4 48.2 17.1
Delta-tocotrienol 6.0 36.4 58.9 4.3 23.8 73.1
Values are calculated based on 200 cells.





























Figure 3 Representative neutral and alkaline comet profiles of A549, U87MG and MRC5 cells treated with tocotrienols. Based on the comet
profiles, mean DNA damage were scored for A549, U87MG and MRC5 cells in response to alpha-, gamma- and delta-tocotrienols treatments for
72 h. Untreated cells show intact nuclei without comet-like appearance. Cells treated with IC50 values of alpha-, gamma- and delta-tocotrienols
showing U87MG cells have higher scores of DSBs than A549 cells and MRC5 DNA damage is negligible. No SSBs are found in all treated cells.
α-T3: alpha-tocotrienol; γ-T3: gamma-tocotrienol; δ-T3: delta-tocotrienol.
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apoptosis in both cancer cells was confirmed. It could be
seen that gamma-tocotrienol did have certain DNA dam-
aging effects on the non-cancerous MRC5 cells, causing a
small amount of DSBs but the DNA damage score was
trivial as compared to that observed in treated A549 and
U87MG cells (Figure 3). The DNA damage scores for both
gamma- and delta-tocotrienols were comparable, while
alpha-tocotrienol was observed to cause less severe DNA
damage than the former two isomers. Similarly, vinblast-
ine also caused DSBs only by which its comet results can
be referred to our previously published report [21].
Cell cycle phase distribution of cancer cells treated with
tocotrienols
Treatments of A549 and U87MG cells with alpha-,
gamma- and delta-tocotrienols increased the ratio of G0/
G1 phase (refer to Pre-G1 staining) as compared to the
control groups at both 24 h (data not shown) and 48 h
as shown in Figure 4. Alpha-tocotrienol at IC80concentration increased cell cycle distribution at G0/G1
stage from 0.8% (untreated) to 11.0% (treated) and 1.4% to
5.5% in A549 and U87MG cells, respectively (Figure 4A).
Comparable trend was seen in gamma-tocotrienol-treated
A549 and U87MG cells at G0/GI stage with increment
from 0.8% in the untreated to 9.1% and 1.4% to 8.7%, re-
spectively (Figure 4B). Among all tocotrienol isomers
tested, delta-tocotrienol at IC80 concentration was found
to execute the highest percentage of cell distribution at
G0/G1 stage with more than 34-fold increase in A549 cells
and 31-fold increase in U87MG cells (Figure 4C). The sig-
nificant increase of the cell proportion at G0 stage, and the
decrease of the cell proportion at GI stage for all alpha-,
gamma- and delta-tocotrienols-treated A549 and U87MG
cells were in fact dose-dependent (p < 0.05).
Caspase-8, Bid and Bax activities of cancer cells treated
with tocotrienols
Alpha-, gamma- and delta-tocotrienols were able to trig-


















Figure 4 (See legend on next page.)
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Figure 4 Representative flow cytometric profiles of A549 and U87MG cells treated with tocotrienols. The effects of (A) alpha-, (B) gamma- and
(C) delta-tocotrienols on cell populations of untreated and treated A549 and U87MG cells at IC50 and IC80 concentrations for 48 h are shown. The fact
with increased cell populations at the Pre-G1 phase of both treated A549 and U87MG cells confirms DNA fragmentation and apoptosis without doubt.
α-T3: alpha-tocotrienol; γ-T3: gamma-tocotrienol; δ-T3: delta-tocotrienol.
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at its basal level (Figure 5). Overall results indicated that
all tocotrienol isomers induced approximately 2 times
greater caspase-8 activation in U87MG cells as com-
pared to A549 cells. The induction peaks of alpha- and
gamma-tocotrienols were detected at its IC50 and IC80
concentrations in A549 and U87MG cells, respectively,
whereas delta-tocotrienol induction peaks were detected
at its ICmax concentration in A549 cells and IC50 concen-
tration in U87MG cells. Study showed that vinblastine did
not induce caspase-8 activation at all concentrations and
treatment time points tested as the caspase-8 level was
similar to that of untreated cells (data not shown). In the
presence of caspase-8 inhibitor, z-IETD-fmk, a clear de-
crease in alpha-, gamma- and delta-tocotrienols-induced
caspase-8 activities was observed somewhat linearly re-
lated to the z-IETD-fmk concentration used (Figure 5).
The percentage of inhibitory effects of 30 μM z-IETD-fmk
in all alpha-, gamma- and delta-tocotrienols-treated A549
and U87MG cells are presented in Table 4.
Figure 6 illustrates that the levels of Bid protein in
A549 and U87MG cancer cells treated with alpha-,
gamma- and delta-tocotrienols increased significantly as
compared to the basal level of untreated samples (p <
0.05). However, when caspase-8 inhibitor, z-IETD-fmk
was added to individual samples prior treatment of the
tocotrienols, it could be seen that the level of Bid protein
was prohibited (Figure 6).
On the other hand, Figure 7 shows that Bax protein
was detected as a specific protein band at 21 kDa in
alpha-, gamma- and delta-tocotrienols-treated A549 and
U87MG cancer cells with higher expression level. In
contrast, there were no band and only a faint band ob-
tained for untreated A549 and U87MG cells, respect-
ively. Results had been validated with a protein loading
control, β-actin with a molecular size of 42 kDa that was
detected in all protein samples.
Alterations of mitochondrial permeability of cancer cells
treated with tocotrienols
The effects of alpha-, gamma- and delta-tocotrienols on
the mitochondrial membrane permeability (MMP) of
A549 and U87MG cells were evaluated for potential in-
volvement of the intrinsic apoptotic signalling pathway.
As shown in Figure 8A, JC-1 reagent taken up in the
mitochondria of vehicle control untreated A549 and
U87MG cells exhibited intense red fluorescence indicat-
ing the cells were healthy with intact mitochondria.However, all cancer cells treated with alpha-, gamma-
and delta-tocotrienols showed intense green fluores-
cence demonstrating JC-1was not able to accumulate in
the mitochondria, which indicates the loss of MMP
(Figure 8B-D). The intensity of the green fluorescence
signal increased in a concentration-dependent manner for
all tocotrienols-treated cancer cells but was comparable
for both 3 h and 24 h treatment periods. Captivatingly,
cells that pre-treated with z-IETD-fmk were not af-
fected by the treatments of alpha-, gamma- and delta-
tocotrienols where JC-1 accumulation within mitochondria
was still apparent (Figure 8B-D). The apoptotic event had
been inhibited by z-IETD-fmk and it is suggested that
caspase-8 has a direct effect on MMP in this case.
On the contrary, vinblastine was found to disrupt the
MMP of both cancer cells negligibly where only very
minimum amount of green fluorescence could be seen
(Figure 8E) and the signal was much weaker than that
of triggered by any tocotrienol isomer tested. This in-
dicates the cancer cells treated by vinblastine retained
intact mitochondrial membranes. This phenomenon
persisted even when the treatment period was in-
creased to 24 h (Figure 8E) and higher concentration at
11 μM was used, majority of the cells were still fluo-
resced red.
Cytochrome c release of cancer cells treated with
tocotrienols
When compared to untreated groups, the cytochrome c
was released at a higher level from both A549 and
U87MG cells treated with alpha-, gamma- and delta-
tocotrienols (p < 0.05). The cytochrome c level in alpha-,
gamma- and delta-tocotrienols-treated cells came close
to the basal level of the untreated vehicle control cells
when caspase-8 inhibitor, z-IETD-fmk was added prior
to the treatment (Figure 9). Upon treatment with IC50
and ICmax concentrations of alpha-, gamma- and delta-
tocotrienols, it could be seen that the cytochrome c levels
increased intensively. The increment percentage is cap-
tured in Table 5. Overall results showed that alpha-,
gamma- and delta-tocotrienols induced higher level of
cytochrome c release in U87MG than A549 cells.
Discussion
Numerous previous studies had demonstrated that toco-
trienols, particularly the most widely studied gamma iso-
form to possess anticancer properties in addition to
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Figure 5 Effects of tocotrienols on caspase-8 activities of A549 and U87MG cells. (A) Alpha-, (B) gamma- and (C) delta-tocotrienols show
distinguished effects on caspase-8 activities of untreated and treated A549 and U87MG cells for 1 h treatment period at the concentrations of
IC50, IC80 and ICmax with or without caspase-8 inhibitor, z-IETD-fmk (10 μM and 30 μM). Generally, alpha-, gamma- and delta-tocotrienols are
able to trigger caspase-8 activities in both treated A549 and U87MG cells. All tocotrienol isomers induced approximately 2 times greater
caspase-8 activation in U87MG cells as compared to A549 cells. α-T3: alpha-tocotrienol; γ-T3: gamma-tocotrienol; δ-T3: delta-tocotrienol.
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its own pharmacodynamic profile [24,25]. The precise
reason why certain isomers are more effective than the
others as antitumor agents is still unclear; but undoubt-
edly, the study on anticancer effects of individual iso-
mers in different cell types is necessary to obtain more
conclusive answers. Although all tocotrienol isomers
share the same basic chemical structure characterized by a
long phytyl chain attached at the 1-position of a chomane
ring, it was found that the location of the methyl groups at
the head region are critical in determining the antiprolifer-
ative and apoptotic activities of individual isoforms [26-28].
Both delta- and gamma-tocotrienols are categorized as
desmethyl tocotrienol owing to their fewer amounts of me-
thyl groups and have been proven to confer higher potency
than the other isoforms [27,28]. Hence, it is of our par-
ticular interest to investigate whether alpha- and delta-
tocotrienol would possess similar cytotoxic capability
as with what reported by other studies for gamma-
tocotrienol, or would they be possibly better. In fact,
studies done on delta- and alpha-tocotrienols are rela-
tively limited as compared to gamma-tocotrienol; add-
itionally, effects of tocotrienols in human glioblastoma
(U87MG) are very rare if not none in any investigations
which are worthwhile to report. Thus, the anticancer
properties of alpha-, gamma- and delta-tocotrienols in
both A549 and U87MG cells are described herein.
Current findings showed that treatments with alpha-,
gamma- and delta-tocotrienols significantly inhibited the
growth of both A549 and U87MG cells in a concentration-
and time-dependent manner (p < 0.05) but caused no
apparent harm towards non-cancerous MRC5 cells. The
IC50 values obtained especially for gamma- and delta-
tocotrienols (Table 2) fulfilled the required anticancer
potency as set by National Cancer Institute (NCI), i.e. <
4 μM [29,30] which warrant further investigations on
their anticancer mechanisms. Delta-tocotrienol with theTable 4 Percentage of inhibition of 30 μM z-IETD-fmk on
caspase-8 activities of tocotrienols-treated A549 and
U87MG cells




Delta-tocotrienol 42.8 61.9lowest IC50 values was found to exhibit the highest anti-
proliferative potency against both A549 and U87MG
cells (Table 2) as compared to the other isomers. Interest-
ingly, alpha-tocotrienol with a weak antiproliferative effect
on A549 cells, was found to possess a slightly higher po-
tency in inhibiting growth of U87MG cells than gamma-
tocotrienol. This suggests that alpha-tocotrienol might
possess selectivity potential towards different cancer types,
i.e. U87MG cells in this case.
Morphological characteristics of apoptosis have been re-
vealed in alpha-, gamma- and delta-tocotrienols-treated
A549 and U87MG cells via histochemical and fluores-
cence staining techniques. These include cytoplasm
vacuolization, cell shrinkage, cell blebbing, formation of
stretched nuclei, chromatin condensation at the nuclear
periphery, appearances of apoptotic nuclei and multinu-
cleated cells. In all cases, the number of cells with changed
morphology was dependent on the treatment concentra-
tions of tocotrienols. Quantification of apoptosis with dif-
ferential scoring of treated and untreated cancer cells
revealed a significant (p < 0.05) increase in the number of
apoptotic cells over time but with insignificant difference
between numbers of necrotic cells in these two cells. All
these observations signified that alpha-, gamma- and
delta-tocotrienols triggered apoptosis instead of necrotic
effects.
The induction of apoptosis in alpha-, gamma- and
delta-tocotrienols-treated cancer cells had been further
confirmed by comet assay (Figure 3). Majority of DNA
migrated towards the tail of the comet after treatment,
which is distinguished to the phenomenon of necrosis,
where the majority of damage would remain in the head
of the comet, although some smaller fragments could es-
cape [31-33]. Conjoining with morphological findings
where chromatin condensation and fragmentation, apop-
totic bodies and so on were evident, it could be concluded
that cellular DNA damage in all tocotrienols-treated cells
was definitely caused by apoptosis. Generally, chemicals or
ionizing radiation may result in many types of DNA dam-
age including SSBs, DSBs, base damage, and DNA-DNA
or DNA-protein crosslinks [34,35]. Current comet profiles
showed only DNA DSBs (neutral comets) were induced
by alpha-, gamma- and delta-tocotrienols in both treated
A549 and U87MG cancer cells. In comparison with previ-
ously published results, vinblastine also generated only
DSBs without SSBs seen in A549 and U87MG cancer cells
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Figure 6 Effects of tocotrienols on Bid protein activities of A549 and U87MG cells. (A) Alpha-, (B) gamma- and (C) delta-tocotrienols are able
to induce higher Bid protein levels on treated A549 and U87MG cells at IC50 and ICmax concentrations for 4 h than the basal levels of untreated
cells. However, 50 μM of caspase-8 inhibitor, z-IETD-fmk is able to suppress the augmentation effects of tocotrienols on Bid protein activities.
*Significance levels (*p < 0.05; **p < 0.01; ***p < 0.001) are set to compare between samples. α-T3: alpha-tocotrienol; γ-T3: gamma-tocotrienol;
δ-T3: delta-tocotrienol.
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Vinblastine has been known to trigger apoptosis through
inhibiting the formation of microtubules and causes mi-
crotubules assemblage [36]. Our current results therefore
suggest that alpha-, gamma- and delta-tocotrienols, which
induced similar DSBs, might also act on microtubules in
both A549 and U87MG cells.
Flow cytometric profiles of both A549 and U87MG cells
treated with alpha-, gamma- and delta-tocotrienols
(Figure 4) revealed an upsurge cell population at the Pre-
G1 phase, which have further confirmed the occurrence of
DNA fragmentation and apoptosis without doubt. Con-
sidering the fact that p21 and p53 are the most import-
ant components controlling the arrest in the G1 and the








Figure 7 Western profiles of Bax protein expression in A549 and U87MG
Bax protein expression at a molecular size of 21 kDa reacted with anti-Bax
gamma- and delta-tocotrienols by which its density is higher than that of u
α-T3: alpha-tocotrienol; γ-T3: gamma-tocotrienol; δ-T3: delta-tocotrienol.checkpoints, the insignificant (p > 0.05) cell cycle arrest
results in the G1 and G2 checkpoints suggest that p21
and p53 are most probably not involved in alpha-,
gamma- and delta-tocotrienols triggered apoptosis. As
mentioned above that the stabilization and activation of
the p53 pathway is usually triggered by the presence of
DNA damage that cannot be repaired [35,38]; thus
guided by the fact that apoptosis initiated by alpha-,
gamma- and delta-tocotrienols did not cause any SSBs,
this again rules out the possibility for the involvement
of p53 pathway [37-39]. However, further investigation
shall be implemented to support such speculations.
Caspase-mediated apoptosis in most cells is known to
involve the activation of either death receptor (extrinsic)








cells treated with tocotrienols. Following 4 h treatment period,
antibody is detected in A549 and U87MG cells treated with alpha-,
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Figure 8 Mitochondrial membrane permeability (MMP) alterations in A549 and U87MG cells treated with tocotrienols and vinblastine.
Representative images showing the effects of (B) alpha-, (C) gamma- (D) delta-tocotrienols at 3 h treatment period on MMP of untreated (A) and
treated A549 and U87MG cells in the presence or absence of caspase-8 inhibitor z-IETD-fmk. Untreated cancer cells possess intact mitochondrial
membranes exhibiting intense red fluorescence, whereas treated cells show deep green fluorescence owing to loss of mitochondrial permeability.
Cells pre-treated with z-IETD-fmk are not affected by either tocotrienol treatment, which still exhibit intense red fluorescence. (E) Representative
images showing the effects of vinblastine at 3 h and 24 h treatment periods on MMP of treated A549 and U87MG cells. Vinblastine induces MMP
very minimally where majority of treated A549 and U87MG cells show strong red fluorescence without being affected by the increased treatment
period and concentration used. Bar: 20 μm. α-T3: alpha-tocotrienol; γ-T3: gamma-tocotrienol; δ-T3: delta-tocotrienol.
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showed that the caspase-8 activities in A549 and U87MG
cells were significantly enhanced after receiving thetreatments of all alpha-, gamma- and delta-tocotrienols
(Figure 5). The activation of caspase-8 has been verified








Figure 9 Effects of tocotrienols on cytochrome c release of A549 and U87MG cells. Cytochrome c levels of A549 and U87MG cells treated with
(A) alpha-, (B) gamma- and (C) delta-tocotrienols at IC50 and ICmax concentrations for 4 h with or without pretreatment of 50 μM of caspase-8
inhibitor, z-IETD-fmk are detected by ELISA. Significantly higher level of cytochrome c is released from all alpha-, gamma- and delta-tocotrienols-
treated A549 and U87MG cells (p < 0.05) than that of untreated counterparts. The caspase-8 inhibitor, z-IETD-fmk has a direct effect in suppressing
the cytochrome c release from treated cells. *Significance levels (*p < 0.05; **p < 0.01; ***p < 0.001) are set to compare between samples. α-T3:
alpha-tocotrienol; γ-T3: gamma-tocotrienol; δ-T3: delta-tocotrienol.
Lim et al. BMC Complementary and Alternative Medicine 2014, 14:469 Page 15 of 18
http://www.biomedcentral.com/1472-6882/14/469
Table 5 Increment percentage of cytochrome c release in
A549 and U87MG cells treated with tocotrienols
Increment of Cytochrome c Release (%)
Treatment A549 U87MG
IC50 ICmax IC50 ICmax
Alpha-tocotrienol 82.2 88.8 65.6 104.7
Gamma-tocotrienol 7.6 14.5 89.1 91.1
Delta-tocotrienol 10.2 19.8 68.4 78.9
Values are calculated as a comparison to the untreated groups.
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to its basal state (Figure 5). A good association between
caspase-8 activation and downstream activities was further
demonstrated on Bid (Figure 6), Bax (Figure 7), MMP
(Figure 8) and cytochrome c (Figure 9) assessments in
alpha-, gamma- and delta-tocotrienols-treated A549 and
U87MG cells. When a similar caspase-8 inhibitor, z-
IETD-fmk was pre-added to the cells, each respective level
of the abovementioned activities had substantially been
suppressed. These observations support the hypothesis
that extrinsic and intrinsic apoptotic pathways are inter-
connected in alpha-, gamma- and delta-tocotrienols-
initiated apoptosis in both A549 and U87MG cells.
Generally, the initiation of the death receptor pathway
(or the extrinsic pathway) involves the recruitment of
adaptor protein procaspase-8 by Fas-associated death do-
main (FADD) on the cell membrane to form the death-
inducing signaling complex [40]. The formation of such
signaling complex will subsequently lead to the cleavage
and activation of procaspase-8 to caspase-8. Then, active
caspase-8 can either stimulate caspase-3 directly resulting
in an immediate apoptosis which is usually regulated by
an abundance of inhibitors for apoptosis; or, it could
sometimes require a more complicated but efficient mech-
anism, which involves the cross-talk between the extrinsic
and the intrinsic pathways [40-42]. For instance, activated
caspase-8 from the extrinsic pathway cleaves Bid (a BH-3
only pro-apoptotic member of the Bcl-2 family) into its
truncated form [42,43], which will then translocate into
the mitochondria (intrinsic pathway) through the activa-
tion of other pro-apoptotic Bcl-2 family members, Bax
and Bak [44,45]. As a result, loss of mitochondrial mem-
brane permeability occurred leading to the release of cyto-
chrome c, followed by the interaction of CARD (caspase
activation and recruitment domain) adaptor protein,
APAF-1 (apoptotic protease activating factor 1) with
procaspase-9, which eventually assemble into an apopto-
some in the cytosol. This caspase-9 activation ultimately
results in the cleavage and initiation of downstream ef-
fector caspases such as caspase-3 [45-47]. Ultimately, all
alpha-, gamma- and delta-tocotrienols-treated A549 and
U87MG cells are subjected to apoptotic cell death as ob-
served in this study.In fact, distinguished recent studies have suggested
that different tocotrienol isomers might exhibit a differ-
ent cellular mechanism of apoptosis in different cancer
types. However, the specific apoptotic mechanisms in-
duced by alpha-, gamma- and delta-tocotrienols in both
brain and lung cancers are still unclear till date. A num-
ber of previous studies had revealed that gamma-
tocotrienol actually acts as an inhibitor of nuclear
factor-κB (NF-κB) p65 protein expression and nuclear
translocation in the human colon cancer HT-29 cells,
resulting in a direct effect on cell cycle progression and
activation of the pro-apoptotic pathway [7]. Neverthe-
less, gamma-tocotrienol was also found in several other
studies to possess cytotoxicity in human gastric carcin-
oma [15] and liver cancer cells [14] through the expres-
sion of Bcl-2 family proteins, increasing the release of
cytochrome c, leading to the activation of procaspase-9
and caspase-3. These incidences further lead to the frag-
mentation of poly (ADP-ribose) polymerase (PARP),
which is responsible in maintaining genomic stability
and DNA-damage-triggered signaling cascade [14,15]. In
fact, a cleaved PARP by caspase-3 during apoptosis is an
irreversible event, where at this stage a cell is fated to
undergo apoptosis and is no longer able to respond to
any DNA damage reparation [14,15], this is widely rec-
ognized as a hallmark for cellular apoptosis [47].
As opposed to that, the involvement of caspase activa-
tion and Bcl-2 modulation was found not to be involved
in gamma-tocotrienol-induced apoptosis in human
breast cancer cells as discovered by Takahashi and Loo
[6]. In their study, apoptosis initiated by gamma-
tocotrienol in human breast cancer cells involved only
the mitochondria-mediated death pathway. Meanwhile,
gamma-tocotrienol was found in prostate cancer model
to suppress cancer metastasis through the induction of
mesenchymal-epithelial transition [16]. Nevertheless,
there are some contradicting opinions that question the
involvement of caspases and modulation of Bax/Bcl-2 in
the gamma-tocotrienol executed apoptotic pathways
[6,7,14,15]. Recent studies of delta-tocotrienol on non-
small cell lung cancer discovered that the anticancer activ-
ity induced by delta-tocotrienol is associated with its abil-
ity to decrease Notch-1, Hes-1, Survivin, MMP-9, VEGF,
and Bcl-XL expressions, with additional decrease of bind-
ing activity in NF-κB-DNA [48,49]. Our current study has
complemented some of these findings where tocotrienols
especially the delta isoform could induce a more effective
apoptotic cell death in A549 and U87MG cancer cells via
caspase-8-mediated Bid and Bax activations. Delta-
tocotrienol is said to be a potent anticancer compound
that can prevent tumor progression not only in non-small
cell lung cancer [48,49] but also in another type of cancer,
i.e. glioma as demonstrated for the first time in our study.
Based on the abovementioned contexts, it is suggested
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and invasion of cancers utilizing multiple molecular path-
ways, which are specific to cancer phenotypes.
Conclusions
This study has provided a structural backbone in map-
ping the apoptotic mechanisms in all alpha-, gamma-
and delta-tocotrienols induced apoptosis in both A549
and U87MG cells (see Additional file 2). It is now re-
vealed that alpha-, gamma- and delta-tocotrienols in-
duce apoptosis through the cross-talk of both the
extrinsic and the intrinsic pathways. This process in-
volves the induction of DSBs leading to the activation
of caspase-8, resulting in the cleavage of Bid and activa-
tion of Bax, which Bax will further translocate into the
mitochondrial membrane leading to the loss of MMP
and causes the release of cytochrome c. This in turn
will result in the execution of apoptosis in both A549
and U87MG cells. However, more studies are necessi-
tated to provide further evidences especially for the
very rarely studied glioblastoma. Future investigations
could recruit other Bcl-2 family members, elucidate the
involvement of the death receptor (Fas-L, Apo2L/
Apo3L, or tumour necrosis factor-related apoptosis in-
ducing ligand), association of p53, microtubule assem-
blage potential, participations of PARP, APAF-1 and
downstream effector caspases to make a better conclu-
sion for the apoptotic mechanisms triggered by toco-
trienols. Nevertheless, findings obtained from this
study have adequately suggested that delta-tocotrienol
is indeed the most effective (higher induction rate) and
efficient (shorter induction time) apoptotic executor
among all isomers tested. Interestingly, tocotrienols
have been reported to be capable of crossing the blood-
brain barrier [50]. Therefore, it is ideal to use the most
potent delta-tocotrienol for chemoprevention and
chemotherapy in glioblastoma owing to its bioavailabil-
ity in the brain.
Additional files
Additional file 1: Caspase-8 kinetic study. Kinetic study of caspase-
8 activity in delta-tocotrienol treated A549 cells. In order to acquire
the most optimum treatment time point for determining the caspase-8
initiation, a kinetic study was carried out in A549 cells receiving delta-
tocotrienol at MIC (1 μM), IC50 (2 μM), IC80 (10 μM) and ICmax (100 μM)
concentrations for different time intervals, i.e. 0 h, 0.5 h, 1 h, 2 h and 3 h.
The 1 h incubation period was chosen for subsequent evaluation of
cellular caspase-8 activity. MIC: minimum inhibitory concentration.
Additional file 2: Proposed apoptotic pathway. Proposed apoptotic
pathway induced by alpha-, gamma- and delta-tocotrienols. Tocotrienol
isomers are proposed to induce apoptosis in A549 and U87MG cell lines
with the involvement of cross-talk between extrinsic and intrinsic pathways
based on the evidences gathered from caspase-8-dependent cleavage of
Bid which led to Bax activation, mitochondrial membrane potential loss
and eventually cytochrome c release, hence resulting the initiation of
downstream effector caspases.Abbreviations
DSBs: Double strand DNA breaks; SSBs: Single strand DNA breaks;
α-T3: Alpha-tocotrienol; γ-T3: Gamma-tocotrienol; δ-T3: Delta-tocotrienol;
AO&PI: Acridine orange and propidium iodide; H&E: Haematoxylin and eosin;
FDA&PI: Fluorescein diacetate and propidium iodide; NCI: National Cancer
Institute; ELISA: Enzyme-linked-immunosorbent assays; SCGE: Single cell gel
electrophoresis; MMP: Mitochondrial membrane permeability; A549: Human
lung adenocarcinoma; U87MG: Grade IV glioblastoma; MRC5: Normal lung
fibroblast.
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